CCL2 and Sepsis: Administering these pro-DCD-specific IgGs significantly increased sepsis-induced systemic accumulation of granulocyte colony stimulating factor (G-CSF), interleukin 6 (IL-6), and monocyte chemoattractant protein 1 (MCP-1)—three established surrogate markers of experimental [27,28] and clinical sepsis [29].